PTC Therapeutics catalysts like Votoplam for Huntington's disease and Vatiquinone for Friedreich's ataxia, offer significant upside. See why PTCT stock is a buy.
Jones Lang LaSalle performance within the Russell 1000 highlights global real estate services, quarterly results, institutional ownership, and capital markets activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results